NASDAQ: HAOHaoxi Health Technology Ltd Stock
$1.06+0.02 (+1.92%)
Updated Jun 16, 2026
HAO Price
$1.06
Fair Value Price
N/A
Market Cap
$492.27k
52 Week Low
$0.78
52 Week High
$285.44
P/E
0.03x
P/B
0.03x
P/S
0.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$42.68M
Earnings
-$2.77M
Gross Margin
4.8%
Operating Margin
-5.44%
Profit Margin
-6.5%
Debt to Equity
0.3
Operating Cash Flow
-$3M
Beta
0.97
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HAO Overview
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the healthcare industry. The company was founded in 2018 and is headquartered in Beijing, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HAO's potential to beat the market
- HAO doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Advertising Agency
Industry Rating
B
HAO
RankedUnranked of 25
RankedUnranked of 25
Be the first to know about important HAO news, forecast changes, insider trades & much more!
HAO News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HAO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HAO was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HAO is good value based on its earnings relative to its share price (0.03x), compared to the US market average (13.25x)
P/E vs Market Valuation
HAO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more HAO due diligence checks available for Premium users.
Valuation
HAO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.03x
Industry
-130x
Market
13.25x
HAO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HAO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HAO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.03x
Industry
2.48x
HAO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HAO's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
HAO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HAO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$20.7M
Liabilities
$4.7M
Debt to equity
0.3
HAO's short-term assets ($15.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HAO's short-term assets ($15.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HAO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
HAO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HAO vs Advertising Agency Stocks
Haoxi Health Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.